Toxicogenomics
Toxicogenomics is defined as the study of the structure and function of the genome and its responds to adverse xenobiotic exposure. It is the toxicological subdiscipline of pharmacogenomics, which is broadly defined as the study of inter-individual variations in whole-genome or candidate gene single-nucleotide polymorphism maps, haplotype markers, and alterations in gene expression that might correlate with drug responses.
- Toxicogenomics in regulatory application
- SAR/QSAR models
- Screening tools to predict toxicity & targets
- Signature/biomarker qualification
- Bioinformatics and interpretive challenges in toxicogenomics
- Challenges of conventional toxicology approaches
- Toxicogenomics as a predictive tool
- Identifying critical targets or pathways
- Gene cloning
- Use of toxicogenomics information directly as a POD
Related Conference of Toxicogenomics
November 13-14, 2025
8th International Conference on Global Toxicology and Risk Assessment
Amsterdam, Netherlands
November 27-28, 2025
7th International Conference on Clinical Pharmacology and Toxicology
Zurich, Switzerland
Toxicogenomics Conference Speakers
Recommended Sessions
- Pharmacology
- Reproductive and Developmental Toxicology
- Biomarkers
- Clinical and Applied Toxicology
- Computational Toxicology
- Drug Toxicology
- Environmental Toxicology
- Experimental and Toxicologic Pathology
- Food and Chemical Toxicology
- Forensic Toxicology
- Human Health Toxicology
- Molecular and Cellular Toxicology
- Occupational and Industrial Toxicology
- Risk Assessments
- Toxicity Testing Market & Business Opportunities
- Toxicogenomics
- Toxicological Pharmacovigilance
- Toxicology
- Toxicology Global Market
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinical pharmacology 2025 (Switzerland)
- Cardiovascular Pharmacology - clinical pharmacology 2025 (Switzerland)
- Clinical Toxicology of Drugs of Abuse - clinical pharmacology 2025 (Switzerland)
- Clinical Trials and Regulatory Affairs - clinical pharmacology 2025 (Switzerland)
- Drug Interactions and Polypharmacy - clinical pharmacology 2025 (Switzerland)
- Emerging Trends in Clinical Pharmacology - clinical pharmacology 2025 (Switzerland)
- Environmental and Occupational Toxicology - clinical pharmacology 2025 (Switzerland)
- Future Directions in Clinical Pharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Innovations in Drug Development and Therapeutics - clinical pharmacology 2025 (Switzerland)
- Natural Products and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neuropharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Pediatric and Geriatric Pharmacology - clinical pharmacology 2025 (Switzerland)
- Pharmacogenomics and Personalized Medicine - clinical pharmacology 2025 (Switzerland)
- Pharmacokinetics and Pharmacodynamics - clinical pharmacology 2025 (Switzerland)
- Toxicology and Risk Assessment - clinical pharmacology 2025 (Switzerland)